Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18770649 | SYSTEM AND METHOD FOR IMPROVING A COGNITIVE STATE OF A PATIENT THROUGH CUSTOMIZED MUSIC THERAPY | July 2024 | February 2026 | Abandon | 19 | 1 | 0 | No | No |
| 18597656 | WELL-BEING PLATFORM UTILIZING MACHINE LEARNING | March 2024 | November 2025 | Abandon | 20 | 4 | 0 | Yes | No |
| 18499979 | VIRTUAL REALITY ENABLED NEUROTHERAPY FOR IMPROVING SPATIAL-TEMPORAL NEUROCOGNITIVE PROCESSING | November 2023 | March 2025 | Abandon | 16 | 1 | 0 | No | No |
| 18287509 | SYSTEM AND METHOD FOR EARLY DETECTION OF A PSYCHOTHERAPEUTIC TREATMENT RESPONSE | October 2023 | February 2026 | Abandon | 28 | 1 | 0 | No | No |
| 18483390 | SYSTEMS AND METHODS FOR IDENTIFYING DEPRESSION IN A DIALYSIS PATIENT | October 2023 | February 2026 | Abandon | 28 | 2 | 0 | Yes | No |
| 18552790 | SYSTEMS AND METHODS FOR INCREASING THERMOMETRIC RELIABILITY | September 2023 | October 2025 | Abandon | 24 | 1 | 0 | No | No |
| 18236789 | SYSTEMS AND METHODS FOR ORGAN SHAPE ANALYSIS FOR DISEASE DIAGNOSIS AND RISK ASSESSMENT | August 2023 | May 2025 | Abandon | 20 | 0 | 0 | No | No |
| 18301697 | SYSTEMS AND METHODS FOR IDENTIFYING RELEVANT STUDIES | April 2023 | September 2025 | Abandon | 29 | 1 | 0 | No | No |
| 18119654 | SYSTEMS AND METHODS FOR EXCLUDED RISK FACTOR PREDICTIVE MODELING | March 2023 | September 2024 | Allow | 18 | 2 | 0 | Yes | No |
| 18179572 | TECHNIQUES FOR FACILITATING VETERINARY SERVICES | March 2023 | April 2025 | Abandon | 25 | 1 | 0 | No | No |
| 18111555 | METHODS AND SYSTEMS FOR DETECTING ENVIRONMENT FEATURES IN IMAGES TO PREDICT LOCATION-BASED HEALTH METRICS | February 2023 | January 2025 | Allow | 22 | 2 | 0 | No | No |
| 18094436 | METHOD AND SYSTEM FOR PREDICTING NEUROLOGICAL TREATMENT | January 2023 | March 2025 | Abandon | 26 | 1 | 0 | No | No |
| 18061154 | SYSTEMS AND METHODS FOR VERIFICATION OF THE APPLICATION OF THERAPEUTIC ENERGY PULSES | December 2022 | September 2025 | Abandon | 34 | 3 | 0 | No | Yes |
| 17973779 | CLOUD SERVER, COMPUTER READABLE MEDIUM, AND CLOUD SYSTEM | October 2022 | September 2025 | Abandon | 35 | 3 | 0 | Yes | No |
| 17932501 | SYSTEMS, METHODS, AND DEVICES FOR REMOTELY DEPLOYED DIAGNOSTIC TESTING | September 2022 | April 2025 | Abandon | 31 | 1 | 0 | No | No |
| 17872092 | ELECTRONIC EVALUATION SYSTEM | July 2022 | October 2024 | Abandon | 27 | 3 | 0 | No | No |
| 17777839 | INFORMATION ACQUISITION METHOD, INFORMATION PROVIDING METHOD, INFORMATION INTERACTION METHOD AND APPARATUS THEREOF | May 2022 | February 2026 | Abandon | 45 | 3 | 0 | No | No |
| 17709838 | REAL-TIME SYSTEM FOR MONITORING AND ANALYZING VOLUME OF SUBSTANCE INTRODUCED INTO THE BODY AND VOLUME OF METABOLIC WASTE EXPELLED FROM THE BODY | March 2022 | November 2024 | Abandon | 32 | 1 | 0 | No | No |
| 17709209 | SYSTEM, METHOD, AND COMPUTER PROGRAM FOR STREAMLINING AUTHORIZATION FOR MEDICAL PAYMENT ADJUDICATION | March 2022 | April 2025 | Abandon | 36 | 1 | 0 | Yes | No |
| 17677918 | MEDICAL CARE SUPPORT DEVICE | February 2022 | August 2025 | Abandon | 42 | 3 | 0 | Yes | No |
| 17677884 | OPTIMAL STIMULATION POSITION CALCULATION METHOD, SERVER AND COMPUTER PROGRAM USING AI MODEL | February 2022 | December 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17635788 | Universal tinnitus management system (UTMS) | February 2022 | November 2025 | Abandon | 45 | 3 | 0 | Yes | No |
| 17567135 | DIAGNOSING SKIN CONDITIONS USING MACHINE-LEARNED MODELS | January 2022 | November 2025 | Abandon | 46 | 3 | 0 | Yes | No |
| 17617293 | INCIDENCE RATE MONITORING METHOD, APPARATUS AND DEVICE, AND STORAGE MEDIUM | December 2021 | February 2026 | Abandon | 50 | 1 | 0 | No | No |
| 17518443 | Communication System and Method | November 2021 | November 2024 | Abandon | 37 | 3 | 0 | Yes | No |
| 17497501 | METHODS AND SYSTEMS FOR TREATING GASTROINTESTINAL AND INFLAMMATORY HEALTH CONDITIONS USING PRESCRIPTION DIGITAL THERAPEUTICS | October 2021 | December 2024 | Abandon | 38 | 1 | 0 | No | No |
| 17497499 | METHODS AND SYSTEMS FOR TREATING HEALTH CONDITIONS USING PRESCRIPTION DIGITAL THERAPEUTICS | October 2021 | December 2024 | Abandon | 38 | 1 | 0 | No | No |
| 17599898 | Non-face-to-face AI occupational therapy assistance system and operating method using blockchain | September 2021 | November 2024 | Abandon | 38 | 1 | 0 | No | No |
| 17487612 | PATIENT MONITORING, REPORTING AND TRACKING SYSTEM | September 2021 | October 2024 | Abandon | 36 | 1 | 0 | No | No |
| 17487479 | SPLIT VISION VISUAL TEST | September 2021 | January 2025 | Allow | 39 | 3 | 0 | Yes | No |
| 17487341 | STORAGE MEDIUM AND PATIENT INFORMATION MANAGEMENT DEVICE | September 2021 | August 2025 | Abandon | 46 | 3 | 0 | Yes | No |
| 17363687 | PREDICTIVE DATA ANALYSIS TECHNIQUES FOR CROSS-TREND DISEASE TRANSMISSION DETECTION | June 2021 | November 2025 | Abandon | 53 | 4 | 0 | Yes | No |
| 17241892 | SECURE REMOTE HEALTH DATA | April 2021 | October 2024 | Allow | 41 | 3 | 0 | Yes | No |
| 17221329 | CONTACT TRACING OF EPIDEMIC-INFECTED AND IDENTIFICATION OF ASYMPTOMATIC CARRIERS | April 2021 | February 2025 | Abandon | 46 | 3 | 0 | Yes | No |
| 17211349 | SYSTEMS AND METHODS FOR IDENTIFYING AND ISOLATING PERSONS SUSPECTED OF HAVING AN INFECTIOUS DISEASE | March 2021 | March 2025 | Abandon | 48 | 2 | 0 | No | No |
| 17200446 | Systems and Methods for Medical Concept Mapping | March 2021 | June 2025 | Abandon | 51 | 3 | 0 | No | No |
| 17033667 | Secure Scalable Real-Time Machine Learning Platform for Healthcare | September 2020 | August 2023 | Abandon | 35 | 2 | 0 | No | No |
| 16962088 | DETECTING RECURRENCE OF A MEDICAL CONDITION | July 2020 | July 2024 | Allow | 48 | 6 | 0 | Yes | No |
| 16314132 | SYSTEM AND ARCHITECTURE FOR SEAMLESS WORKFLOW INTEGRATION AND ORCHESTRATION OF CLINICAL INTELLIGENCE | December 2018 | May 2025 | Abandon | 60 | 8 | 0 | No | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HANKS, BENJAMIN L.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner HANKS, BENJAMIN L works in Art Unit 3684 and has examined 16 patent applications in our dataset. With an allowance rate of 18.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 46 months.
Examiner HANKS, BENJAMIN L's allowance rate of 18.8% places them in the 2% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by HANKS, BENJAMIN L receive 2.81 office actions before reaching final disposition. This places the examiner in the 82% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by HANKS, BENJAMIN L is 46 months. This places the examiner in the 11% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +42.9% benefit to allowance rate for applications examined by HANKS, BENJAMIN L. This interview benefit is in the 89% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 11.5% of applications are subsequently allowed. This success rate is in the 6% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 3% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
This examiner withdraws rejections or reopens prosecution in 0.0% of appeals filed. This is in the 2% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.